Trump Action Archive

Supporting reports

• OMB proposes rule placing federal research grants under political appointee control — On May 29, 2026, OMB Director Russ Vought proposed a rule that would place all federal research and discretionary grants under the control of political appointees rather than scientific experts. The rule would prohibit grants that "promote anti-American values" and require awards to "demonstrably advance the president's policy priorities." Stand Up for Science estimates nearly half of approximately 10,000 NIH-funded clinical trials could be discontinued, including over 1,000 cancer trials, pediatric studies, and trials addressing veterans' health, suicide, heart disease, and diabetes. The public comment period closes July 13, 2026.
• Trump administration proposed merit-based federal research grant system be replaced with political appointee approval — On May 29, 2026, the Trump administration proposed dramatic changes to federal research grant awards. Rather than continuing the merit-based system established through rigorous peer review, grants would be awarded based on approval by political appointees. The Office of Management and Budget, directed by Christian nationalist Russell Vought, would control grant allocation. The proposal limits foreign collaboration and allows the OMB to revoke grants deemed to fail "program goals, Federal agency priorities, or the national interest."
• Russell Vought proposes political control over research grants — Russell Vought, director of the Office of Management and Budget and co-author of Project 2025, proposed on May 28 that political appointees in his office should have final say over research grants, including those for the National Institutes of Health, the National Science Foundation, and other governmental science agencies. The proposal aims to root out what it characterizes as a "woke" policy agenda and would also require approval by political appointees for international research collaboration.

Supporting reports

• FDA sends serious enforcement letter to pharmaceutical company; CEO donates $1 million to Trump super PAC days later — On May 26, the FDA sent a letter to pharmaceutical company QOL Medical containing serious allegations that could threaten the company's existence. Days later, QOL Medical CEO Frederick Cooper donated $1 million to MAGA Inc., Trump's super PAC. The timing and sequence raise questions about whether the donation was made in response to the regulatory threat or as an attempt to influence the agency's enforcement action.
• FDA sends warning letter to QOL Medical for false drug advertising — On May 26, 2026, the FDA sent a warning letter to QOL Medical accusing the pharmaceutical company of using "false or misleading" advertising to promote Sucraid, a drug for treating congenital sucrase-isomaltase deficiency (CSID). The FDA alleged that QOL Medical's marketing materials encouraged doctors to prescribe Sucraid for patients with IBS-like symptoms (gas, bloating, diarrhea, nausea), despite the drug being unable to treat IBS or its symptoms. The FDA determined QOL Medical violated the Federal Food, Drug, and Cosmetic Act's prohibition on drug misbranding. The letter required QOL Medical to respond within 15 working days.